Innovative Diagnostic Solutions NovaSom has developed FDA-cleared home sleep apnea testing devices that are clinically equivalent to traditional polysomnography, offering a compelling alternative that can be marketed to healthcare providers seeking cost-effective and patient-friendly diagnostic options.

Partnership Expansion Following the acquisition by SleepMed, there is a strategic opportunity to leverage SleepMed’s extensive sleep lab network to cross-sell NovaSom’s home testing solutions and expand market reach within clinical environments.

Growing Market Demand With millions of undiagnosed sleep apnea patients and increasing awareness about sleep health, there is substantial potential to target primary care and specialty physicians who can incorporate NovaSom’s innovative devices into their diagnostic pathways.

Funding & Revenue Growth NovaSom’s recent $6.1 million debt financing and revenue range of $10 million to $25 million indicate solid financial stability and growth potential, making them an attractive partner for sales initiatives aimed at expanding product adoption.

Technological Edge The company's use of advanced tech stack including cloud-based analytics and secure web platforms presents opportunities to integrate with broader healthcare IT systems, enhancing data management and facilitating seamless adoption by healthcare organizations.